ATE408400T1 - Pharmazeutische zusammensetzung mit verzögerter freisetzung - Google Patents

Pharmazeutische zusammensetzung mit verzögerter freisetzung

Info

Publication number
ATE408400T1
ATE408400T1 AT02076991T AT02076991T ATE408400T1 AT E408400 T1 ATE408400 T1 AT E408400T1 AT 02076991 T AT02076991 T AT 02076991T AT 02076991 T AT02076991 T AT 02076991T AT E408400 T1 ATE408400 T1 AT E408400T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
delayed release
release pharmaceutical
formulation
drug
Prior art date
Application number
AT02076991T
Other languages
English (en)
Inventor
Inger Norden
Peter Fyhr
Catarina Carling
Original Assignee
Watson Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Watson Lab Inc filed Critical Watson Lab Inc
Application granted granted Critical
Publication of ATE408400T1 publication Critical patent/ATE408400T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02076991T 2002-05-21 2002-05-21 Pharmazeutische zusammensetzung mit verzögerter freisetzung ATE408400T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02076991A EP1364644B1 (de) 2002-05-21 2002-05-21 Pharmazeutische Zusammensetzung mit verzögerter Freisetzung

Publications (1)

Publication Number Publication Date
ATE408400T1 true ATE408400T1 (de) 2008-10-15

Family

ID=29286190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02076991T ATE408400T1 (de) 2002-05-21 2002-05-21 Pharmazeutische zusammensetzung mit verzögerter freisetzung

Country Status (5)

Country Link
EP (1) EP1364644B1 (de)
AT (1) ATE408400T1 (de)
DE (1) DE60228939D1 (de)
ES (1) ES2312525T3 (de)
HK (1) HK1062632A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432254B (zh) * 2021-12-30 2023-05-16 南通联亚药业股份有限公司 一种硝苯地平控释片

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
IL104192A (en) * 1992-02-17 1998-01-04 Siegfried Ag Pharma Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
JP3220373B2 (ja) * 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity

Also Published As

Publication number Publication date
DE60228939D1 (de) 2008-10-30
HK1062632A1 (en) 2004-11-19
ES2312525T3 (es) 2009-03-01
EP1364644B1 (de) 2008-09-17
EP1364644A1 (de) 2003-11-26

Similar Documents

Publication Publication Date Title
SE0004671D0 (sv) Pharmaceutical formulation
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR044926A1 (es) Sistema de suministro de farmacos gelificante in situ
ATE432692T1 (de) Tabletten, die in der mundhöhle schnell zerfallen
AR044964A1 (es) Formulaciones para microproyecciones recubiertas que contienen contra-iones no volatiles
AR044077A1 (es) Peliculas consumibles por via oral que se disuelven rapidamente, que contienen un edulcorante
CU23440B7 (es) Composición de liberación sostenida de pramipexol
CY1109606T1 (el) Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο
UY28304A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
WO2003018075A3 (de) Transdermales therapeutisches system mit fentanyl bzw. verwandten substanzen
AR015946A1 (es) Formulacion farmaceutica que comprende bifosfonatos, proceso para su preparacion, uso de la formulacion para la fabricacion de un medicamento, metodo parala inhibicion de la reabsorcion osea, y metodo para el tratamiento y prevencion de osteoporosis
BR9912066A (pt) Uso de um ingrediente ativo; método de tratamento de restenose; e; composição farmacêutica
ITMI922603A1 (it) Composizioni farmaceutiche comprendenti un farmaco, una sostanza polimerica reticolata, un olio ed un agente tensioattivo
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
ATE361060T1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
BR0114897A (pt) Preparação farmacêutica hidrofìlica contendo nateglinida, e, método para a preparação da mesma
ATE408400T1 (de) Pharmazeutische zusammensetzung mit verzögerter freisetzung
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
DOP2006000184A (es) Forma farmacéutica con liberación sostenida independiente del ph de un ingrediente activo, para ingredientes activos que tienen una solubilidad que depende en gran medida del ph
AR044983A1 (es) Solidos con capa de difusion modulada
WO2000041481A3 (de) Arzneiformen mit gesteuerter freisetzung, enthaltend gut wasserlösliche wirkstoffe
DK1275383T3 (da) "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof
AR030964A1 (es) Una formulacion farmaceutica con una matriz que forma un gel hidrofilico, formulacion que comprende una o mas sustancias activas, y metodo para preparar tal formulacion que tiene una liberacion prolongada sustancialmente independiente de la fuerza ionica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee